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Qbjecrives. ‘This tudy was conC;ucted ts examine w&ether b 
coronary artery tone is elevated in patients with variant 
coronary artery tone was greater < 0.05) at the spastic 
Coronary artery tone is regulated bythe net effects of various 
vasoconstrictor andvasodilator stimuli such as the autonomic 
nervous ystem, humoral factors and endotheli~m-delved 
vasoactive substances. In patients with variant angina, con- 
strictive r sponses to the diverse vasoconstricting stimuli are 
augmented at the spastic site, and coronary artery spasm 
results from local hyperreactivity of the coronary artery seg- 
ment o stimuli that produce only mild constriction atthe 
nonspastic site (1,2), The results of experimental studies in a 
swine model of coronary spasm are largely consistent with 
those of clinical studies (3-7). However, previous data have 
been inconclusive asto whether basal coronary artery tone 
(that is, the vasodilating response tonitrate vasodilators) is 
elevated atthe spastic site. Several studies (S-10) have dem- 
onstrated such elevation, whereas others (2, I l-13) have found 
no difference b tween basal coronary artery tone at spastic and 
nonspastic s tes. The present s udy was designed 1)to examine 
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artery tone is elevated at 
ant aloha, and 2) to det 
nary artery tone in predicti 
cation of coronary artery spasm. 
salt The study was performed in 20 patients 
with variant angina and 24 control subjects undergoing 
diagnostic cardiac atheterization. The patients with variant 
angina (17 men and 3 women with a mean age of 50 + 10 
years) had typicaY episodes of chest pain at rest associated 
with ST segment elevation on the electrocardiogram (ECG). 
In these patients,, arteriographically documented coronary 
artery spasm was provoked by intracoronary administration 
of ergonovine and was associated with chest paiu and ST 
segment elevation. The control subjects (IS men and 9 
women with a mean age of 52. t 10 years) had atypical chest 
pain and normal exercise test results but no provocation of
coronary spasm by intracoronary ergonovine. All patients in
both groups had angiographical!y normal coronary arteries; 
that is, they had no atherosclerotic lesion on angiograms 
takeu after intravenous nitroglycerin (0.2mg bolus injection 
followed by 0.02 mg/min for 3 in). Patients who 
previous myocardial infarction, valvuiar heart disease or 
congestive heart failure were excluded from the study. The 
clinical and angiographic characteristics of the patients are 
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Clilkal iXid ~~~~jO~~~~~C Characterislics of PaPients ~-~ ____-_ 
- P1 &I: @I$ ECG Sk of ST % Llamew Reduction at the Spastic Site 
NO. ‘Liender Segment t (dose of ergonovine in p.g) 
-. 
P Il,lll,aVF Seg 1: 79Lii.liIS); aeg 3: 8l%iSO) 
2 I.ILaVL,V,-V, Seg 6: mO%~5) 
, BP.lll.aVF Seg 2: 90%0(E): seg 3: UW?&P4) 
4 37/M I,aVL,V,-V, Seg 6: 80%(50); seg 7: mJ%/c:50); seg 84: 1 
5 58/L II.III,aVF Seg 3: w%(5): 4.&V. ! 
No changes Seg 11: 75%(5Q) 
6 23/M II.IBP,~VF,V,-V, Seg 8: lOO%b(50); seg 14: ltM%(SO) 
7 61/M aVL,V,,V, Seg II. 1OO%0) 
s 40/M II,III,aVF Seg 3: 94%(5); 4AV: Poe%(5) 
No changes Seg 3: 910/o(5) 
9 65/F I.aC L,V,-V, Seg 9: 100%‘0(5) 
10 46/M Il,lnH,aVF Seg I: 79%(50) 
I,aVL,V,V, Seg 5: Ml%$): zee ID: 99%(S) 
IP 581 Il.111 4AV: IOO%(5), 
aVL Seg 12: 76%(50) 
I? 58M Il,lll.aVF Seg3: 100%(P); 4AV: BOO%~l); 4PD: 100%(l) 
I3 .58/M Vz-v, Seg 8: 78%~(50) 
14 58/M l~,~~~,aV~.V,-V., Seg 7: lO4I%(4) 
I5 43/M II Seg I: 750%(50): seg 3: 83%(5OP 
I6 W/F li.Pil,aVF Seg 7. w&i,. seg 1 I: w/i’(s,; beg 13: ?8%(5). 
Seg 14: ItlOW) 
17 45/F Il,inl,aVF Seg I: 83%(5); seg 2: 82%i(5); seg 3: 79%(5), 
- _--_ 
Anti;.~ginau Diugs 
(doseldajr in rogj 
Ix82OJ 
D(i20D: NC(m) 
NFW; I(80) 
D(240); 1(80) 
rw@x H(120); NCdPS) 
IX 120); 1(&o) 
NF(20); U40) 
NF(20); i(40) 
I8 46/M 
19 56/M 
20 56/M 
No changes 
Il,lll,aVF 
Il,lll.aVF 
aVL,V, 
IILaVF 
Seg 11: 1oO%I5) 
Seg 3: 99%150) 
Seg 2: 100%(l) 
Seg 7: 76%(5): 3rd: 79%(5); seg II: lOO%‘c(5) 
Seg 6: llXW5) 
NF(40) 
NF140): I(IZO) 
D(W3) 
The segment numbers are indicated according to the definition of the American Heart Association Committee Report (9). Antianginal drugs are those that were 
discontinued ~24 h before catheterization. D = diltiazem; EC6 = electrocardiogram; F = female: 4AV = posterior left ventricwlar artery branching 
atrioventricular node artery; 4PD = posterior descending artery: I = isosorbide dinitrate: NC = nicorandil; NF = nifedipine: M = male; Pt = patient; Seg = 
segment: 3rd = third tranch; t = elevation. 
summarized in Tables I and 2. 
days before catheterization, 11 patients with variant angina 
and 3 control subjects were takirag a~t~a~gi~a~ medications 
(Tables 1 and 2). Although use of sublingual ~itrog~ycer~~ 
was pelIlllrlG;rt IR LIGLU~U, 1IU IJUUG1IPC a.. “es.._. o’--r -- . .--f---J :c -....dnA ..c. not;nnt ;n ,&h,al. Drnaln ,lred it 
within 6 h befcrc athekrization. All studier were pe~ormed 
in the morning (9:OO AM to 12:oO AM). Coronary arteriogra- 
phy was performed with use of a femoral approach an 
angiograms were recorded using a Semen5 cineangiograph 
system. An appropriate view that allowed clear visualization 
of the coronary artery was selected and us.t:d throughout the 
study. The distances from the X-ray fcpcus 10 the patient and 
from the patient to t e image i~te~si~er were 
during the study. 
After control coronary arteriography was performed. 
ergonovine was administered into the left :m ht coronary 
arteries cumul&ively at doses of 5, 10 and 35 pg to a total 
dose of 50 pg in 24 control subjects and 13 patients with 
variant angina. In the other seven patients with variant 
angina, the dose of intracoronary ergonovine was started at 
[ ~g to determine the dose-response r lation with ergono- 
lumen diameter of t 
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Table 2. Clinical and Angiographic Charac:eristics of Contwl Subjects 
‘5 Constriction by Ergonovine 
Subject Age ( yr)i 
No. Gender Basal Tone 5&g 15 I% 50 erg 
- 
Antianginal Drugs 
(dose/day in mgt 
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I 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
I! 
I3 
I4 
IS 
I6 
I7 
IH 
I9 
20 
!I 
22 
23 
24 
57/F I3 t 8 
.51/M I4 + 7 
55/M 9+5 
54/F I6 t 5 
40/M II +7 
46/M I8 i: 9 
49/M IZi: II 
61/M 16% II 
61/M I7 f 9 
72/F I8 + IO 
431M I4 + 9 
56/F I6 j: IO 
60/M II 27 
51/F 20 + 7 
43/F 629 
42/M 162 II 
SS/M 25 + 9 
30/M 827 
WF I5 + 7 
36/F I.5 + 7 
03/F 28 + 6 
54/M 627 
46lM 23 + 7 
SO/M 22 + II 
ND 
ND 
122 IP 
I7 % 5 
I8 -c 8 
36 1 10 
II 5 I! 
ND 
24 2 9 
ND 
ND 
ND 
ND 
14 + IO 
13 2 I! 
I9 It H 
30 x 9 
IX c IO 
!O i 9 
I8 + IO 
33 t 7 
ND 
28 + 8 
27 + I4 
2s + 8 
Iii ?: 9 
14% II 
24. % 7 
16 ?: 9 
42 + 9 
I2 * 9 
NIP 
33 + 3 
ND 
22 + 8 
ND 
ND 
I9 + s 
17 ?z IO 
25 2 8 
29 z 8 
20 + 9 
24 + II 
14 + II 
31 + IO 
ND 
27 + 10 
302 I3 
26 i: 8 
14 2 7 
19 + I3 
30 f 6 
21 +8 
37 2 I5 
18 c9 
29 + 7 
39-L IO 
242 14 D(8OL l(94) 
28 ? 5 
22 ?r 5 
II J- 8 
17 + 9 _” -- 
24 + 8 
31 It 10 
32 + 8 
30 + 9 
!6 + II NH401 
!hL! I! 
3s + 8 
30 2 22 DI 1201 
34 c 9 
3s + II 
Percent constriction by ergonovine and coronary artery tone in ench subject are expressed us mean + SD of the 
measurements in I3 to IS coronary urtery segments. ND = not determined: other abbreviations us in Tnbte I. 
sured at every coronary segment as classified by the Amer- 
ican Heart Association (14). CIowevcr. small coronary arter- 
ies (diameter <I mm after nitroglycerin) or segments 
overlapped by other branches were not analyzed. The in- 
trnobserver and interobserver correlation for coronary diam- 
eter measurements were r = 0.99 (p < 0.0001) and r = 0.96 
(p < O,Wl), respectively (15). 
Basal coronary artery tone and percent constriction pro- 
duced by ergonovine were calculated as follows: 
Basal coronary artery tone (5%) = 
Diameter after nitroglycerin - Baseline diameter 
Diameter aikr niirugijuxiii 
x 100. 
Coronary artery constriction by ergonovine (9%) = 
Diameter after nitroglycerin - Diameter after ergonovine 
Diameter after nitroglycerin 
--x loo. 
Coronary artery spasm was defined as ~75% coronary 
artery constriction after ergonovine. In control subjects, 
basal coronary artery tone and coronary artery constriction 
after ergonovine were examined in I2 to 15 segments and the 
mean values were used for later analysis because variability 
of the measurements among the segments in the same 
control subject was low. In patients with variant angina, 
these variables were analyzed in each segment because these 
data varied among the segments. 
ostic sensitivity and specificity were de 
Diagnosiic sensitivity (Q) = 
True positive 
--x 100. 
True positive t False negative 
Dial:nostic specificify (%I = 
True negative 
True negative + False positive 
The true positive value indicates the number of spastic 
sites in which basal coronary artery tone was above the 
dizqostic criterion of basal coronary artery tone. The false 
--n*Ara WIIIP jn~-Iirat~c he nl mhpr nC q-,pqtic sites in which Il~j+U..* .U.“I ..“.I...“” . .._ ..-.._ __-. _. .‘ 
basal coronary artery tone was below the diagnostic crite- 
rion of basal coronary artery tone. The true negative value 
implies the number of nonspastic sites in which basal coro- 
nary artery tone was below the diagnostic criterion. The 
false positive value implies the number of nonspastic sites in 
which basal ;oronary artery tone was above the diagnostic 
criterion. 
Statistics. Values are expressed as mean value I: SD. We 
used the unpaired t test for comparison of basal coronary 
artery tone and hemodynamic variables between thz patient 
and control groups. For comparison f basal coronary artery 
tone between the spastic and nonspastic sites, the paired t 
test was used. To compare the dose-response relation with 
ergonovine among patients w&h variant angina nd control 
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ororlary Artery Tone an 
Rtiem With 
Control Subjects Varian’ Angina 
-- ~-- 
Diameter .41trr E~gOl-Wk Diamh3 .M!er 
Nitroglycerin asal Tone Response Nitroglycerin 
(mm) @‘o) @z) (mm) 
Seg I 4.B 2 0.93 142 11 262 14 3.70 + 1.05 
Seg 2 3.56 + 0.61 is i 13 30 -‘- PO 3.36 z! 0.93 
Seg 3 3.31 r 0.75 162 11 32 ” BO 3.30 ?r Q.65 
4AV 2.28 5 0.60 162 7 27 + 10 2.57 k 0.72 
4PD 2.33 + 0.51 17-c II 30 !I II 2.19 2 0.44 
Seg 5 4.77 2 0.17 7 k 7” I5 r II* 4.40 + I.15 
Seg 6 3.88 t 0.62 13 + 9 24 I 14. 3 44 1 0.95 
Seg 7 3.03 i: 0.63 18 L IO 28 2 II 2.x, t 0.72 
Seg 8 2.07 4 0.59 PK ?z 13 25 + PO 2.24 1: 0.55 
Se&? 9 2.14 ? 0.49 16 + 9 26 2 10 1.88 + 0.60 
scg IO 1.98 t 0.81 19 Lc I4 25 rt 14 1.94 i: 0.60 
scg I I 3.41 ? 0.58 Ih 2 III 281 13 1.19 ?: 0.81 
scg I! 2.00 + O.dI! I4 rt 10 47 F 9 2.4‘4 -c 0.80 
Seg I3 ?.@I + 0.9! IR + 10 28 f II 2.40 t- 0.49 
Seg 14 2.08 2 0.61 I7 -c 9 25 + IJ 2.08 1; 0.90 
*p < 0.01 versus other %egmen?s. Abbreviations as in Table 1. 
two-way analysili of variance 
e relation between 
rences among trans 
coefficients were examined by taki 
patients with variant angina (Table I). a total of 46 spastic 
segments and 231 nonspastic segments were anaiyred. Cor- 
onary artery WYS~ occurred in 4 segments after a dose of 
1 26 pg, segme IIS after 5 3 p.g, segments after 15 pLg and 13 
segments after 50 pg of ergonovine. In 24 control subjects 
(Table 2), 202 segments were analyzed and neither coronary 
artery spasm nor chest pain was provoked by ergonovine. 
The coronary artery diameter after ~itrog~yce~~ in patients 
with variant angina and control subjects and the basal 
coronary artery tone and vasoconstrictive response to er- 
gonovine in control subjects are shown in Table 3. Segment 
diameter after ~~t~ogiyceri~ was similar m the control and 
the patient groups. In control subjects, basal coronary artery 
tone and ergonovine response were significantly lower in 
segment 5 han in other segments but otherwise did not ditfer 
I i 1 ._ 
3 15 501U9~ 
NON-SPASTIC SITE 
CL~J~L~ATIVE DOSE OF ERGONOVINE 
ke 1. The cudalive dose-response curves with e~~Q~~v~~e in 
patients with variant angina and control subjects. IJ 
= 24). Percent lumen reduction was calculated by the 
C = the control conditicn before ergonovine (that is, basal coronary 
artery tone). *p < 0.05, +*p -=z 0.01 versus co~espcnbing value in 
cordrol subjects. 
ong segments. Figure 1 su 
vasoconstrictive response TV ergonovine at the graded oses 
in the patients and controi subjects. lfn patien riant 
angin:a, the dose-response relation was plott sub- 
group in which spasm was provoked by 1.5, 15 or 50 pg of 
argonovine. The dose-response relation at 
was bitted to the left in the subgroups in w 
provoked by ergonovine atthe lower doses ( 
panel). 
~-0 *=an&tl& .rf ~~~o~ov~~e-~~duced v I.._ ‘L..+DS“.~ll _. _~u 
the nonspastic sites was greater (p < 0.01) 
variant angina in whom spasm was prov 
ergonovine than in the control subjects (Fig. 1, lower panel). 
The dose-response relation in patients in 
provoked by 15 pg of ergonovine did not 
the control subjects. The rna~~it~de of c 
with I§ and SO pg of ergonovine inpatie 
was provoked by 50 pg of ergonovine was 
38 -t 14%, respectively, values slight 
as a whole, average basal coronary artery tone was signifi- 
%
 L
U
M
E
N
 R
E
D
U
C
T
IO
N
 
B
Y
 E
A
G
O
N
O
V
IN
E
 
CORONARY ARTERY TONE 
nostic sensitivity and speci 
spss 
is sites was 46 and that 0 
patients with variant angina. 
that basal ~~~~~a~ artery to 
higher in such patients than 
presertr study. Among possible nonspecrfic ~ec~a~is~s that 
itude of basal coronary 
drugs or inuation of smok- 
ever, we consider it that hese mech- 
anisms infkinced basai coronary artery tow in Our patients. 
1) All ~~tia~gi~a~ drugs were scontinued Z-24 hbefore the 
study and all studies were ne in the msrning~ Thus, it 
appears that he influence ofthe residual eEect ~~a~tia~~~a~ 
drugs or diurnal variation of basal coronary artery tone was 
a, deceived a t&at dose 0 
reported by previous invesrigators (8-13) and the diameter in
each coronary segmmt after ad~i~~st~t~~~ 
in ~Q~t~~~ subjects was not smaller than that 
variant angina. These ines of evidence stm 
the basal coronary artery tone in our cm 
not ~~de~est~~ated. 
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sensitivity to ergonovine atthe site of spasm varied among 
Patients with variant angina, is consistent with the results Of 
Matsuda et al. (20), who found that he degree of constriction 
evoked with a small dose (0.02 mg) of intravenous ergono- 
vine varied widely (15% to 73%) at the site where coronary 
spasm was provoked by a large dose (0.2 mg) of intravenous 
ergonovine. 
ergonovine. The results not only explain the inconsistency in 
the results of previous studies on elevation 
artery tone in Patients with variant angina 
that elevated basal coronary artery tone 
Predicting Provocation ofcoronary spas 
The dose of ergonovine required for provocation of 
spasm correlated negatively with basal coronary tone at the 
spastic site. Moreover, in patients inwhom coronary spasm 
was provoked by the low doses (1 or 5 ~~91 of ergonovine, 
basal coronary attery tone and the magnitude of constrictive 
response toergonovine were greater at both the nonspastic 
and spastic sites. These results uggest that he abnormality 
that elevated basal coronary artery tone also enhanced the 
sensitivity o ergonovine and affected not only spastic but 
also nonspastic sites. Kaski et al. (2) demonstrated hat basal 
coronary artery tone at nonspastic sites was elevated during 
a spontaneous attack of spasm in patients with variant 
angina. They speculated that spontaneous coronary spasm 
results from a locally exaggerated coronary constrictive 
response to generalized stimuli that produce only mild 
constriction atthe nonspastic site. According to this hypoth- 
esis, the level of generalized constrictor stimuli may deter- 
mine basal coronary artery tone and the sensitivity to 
ergonovine. It appears that coronary spasm can be provoked 
with the low dose of ergonovine when basal coronary artery 
tone is elevated by enhanced generalized stimuli. When 
generalized stimuli are extremely enhanced, coronary artery 
tone at the spastic site becomes so elevated that myocardial 
ischemia occurs without provocation (that is, spontaneous 
spasm). Conversely, when generalized stimuli are not so 
enhanced, basal coronary artery tone is not elevated and the 
high dose of ergonovine is required to induce coronary 
spasm. The difference incoronary artery tone between the 
spastic and nonspastic sites may result from the difference in 
the magnitude of constrictive r sponse to generalized stim- 
uli. 
We are very grateful to Hiroaki Shimokawa, MD for constructive comments. 
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